Table 2.

Summary of tracer trials currently in phase 2 and beyond.

Presenter	Tracer	Tumor type
Eben Rosenthal, MD	Anti-EGFR antibody	Head and neck malignancies
Linda W. Martin, MD, MPH	TumorGlow	Lung cancer, soft tissue sarcomas
Baran Sumer, MD, FACS	pH-sensitive tracers	Prostate cancer